April 25, 2016

Community Hospital East To Offer New Melanoma Treatment

Community Hospital East To Offer New Melanoma Treatment

INDIANAPOLIS (AP) — An Indianapolis hospital will begin treating melanoma patients with a new drug that uses a modified virus to infiltrate and destroy deadly skin cancer tumors.

Community Hospital East says it will soon start treating patients with the injectable drug from Amgen Inc. for patients with hard-to-treat melanoma.

The drug, Imlygic, is injected directly into tumor tissue, where it uses the herpes virus as a Trojan horse to slip past and rupture cancer cells. It also creates an anti-tumor response in patient's immune system.

The virus is modified so that it only replicates within cancer cells, while leaving healthy cells alone.

This immunotherapy drug was approved late last year by the Food and Drug Administration.

Support independent journalism today. You rely on WFYI to stay informed, and we depend on you to make our work possible. Donate to power our nonprofit reporting today. Give now.

 

Related News

Biotech company will invest $550 million in Indianapolis facility over the next five years
Eli Lilly expands partnership with Purdue by $250 million
IDOH to investigate Floyd County tick disease death, urges Hoosiers to protect themselves